Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM
Holding DE:BRM?
Track your performance easily
See the Price Targets and Ratings of:
BRM Analyst Ratings
Hold
2 Buy
9 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BRM Stock 12 Month Forecast
Average Price Target
€43.45
▲(1.03% Upside)
| Highest Price Target€55.32 | Average Price Target€43.45 | Lowest Price Target€29.53 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
08/22/24
Jefferies
Assigned
08/20/24
TD Cowen
Assigned
08/12/24
Argus Research
Reiterated
07/30/24
Deutsche Bank
Assigned
07/30/24
Leerink Partners
Reiterated
07/29/24
Morgan Stanley
Reiterated
07/29/24
Goldman Sachs
Reiterated
07/29/24
Truist Financial
Assigned
07/29/24
Bank of America Securities
€49.07
Hold
14.10%
Upside
Assigned
07/29/24
Bristol-Myers Squibb: A Hold Rating Amidst Short-Term Gains and Long-Term Uncertainties
Wells Fargo
€46.4
Hold
7.87%
Upside
Reiterated
07/15/24
Hold Rating on Bristol-Myers Squibb Amid Balanced Strengths and Long-Term Revenue Concerns
Citi
€66.92
Buy
55.59%
Upside
Reiterated
05/21/24
Citi reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)Citi analyst Andrew Baum reiterated a Buy rating and $75.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY)
HSBC
€40.15
Hold
-6.65%
Downside
Reiterated
05/01/24
Hold Rating on Bristol-Myers Squibb Amid Earnings Uncertainty and Strategic Investments
DZ BANK AG
€54.43→€44.61
Buy
3.73%
Upside
Reiterated
04/30/24
Bristol-Myers Squibb Co. (BMY) PT Lowered to $50 at DZ BankDZ Bank analyst Elmar Kraus lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $50.00 (from $61.00) while maintaining a Buy rating.
Best Analysts Covering Bristol-Myers Squibb
Which Analyst Should I Follow If I Want to Buy DE:BRM and Sell After:
1 Month
xxx
Success Rate
8/17 ratings generated profit
Average Return
+0.74%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.06% of your transactions generating a profit, with an average return of +0.74% per trade.
3 Months
xxx
Success Rate
11/17 ratings generated profit
Average Return
+3.36%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +3.36% per trade.
1 Year
Success Rate
15/17 ratings generated profit
Average Return
+12.98%
reiterated a sell rating 27 days ago
Copying Terence Flynn's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +12.98% per trade.
2 Years
xxx
Success Rate
14/17 ratings generated profit
Average Return
+16.89%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.35% of your transactions generating a profit, with an average return of +16.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BRM Analyst Recommendation Trends
Rating
Apr 24
May 24
Jun 24
Jul 24
Aug 24
Strong Buy
0
1
1
1
0
Buy
7
7
7
4
3
Hold
26
26
22
18
13
Sell
3
2
2
4
6
Strong Sell
0
0
0
0
0
total
36
36
32
27
22
Each month's total comprises the sum of three months' worth of ratings.
BRM Financial Forecast
BRM Stock Forecast FAQ
What is DE:BRM’s average 12-month price target, according to analysts?
Based on analyst ratings, Bristol-Myers Squibb’s 12-month average price target is €43.45.
What is DE:BRM’s upside potential, based on the analysts’ average price target?
Bristol-Myers Squibb has 1.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bristol-Myers Squibb a Buy, Sell or Hold?
Bristol-Myers Squibb has a consensus rating of Hold, which is based on 2 buy ratings, 9 hold ratings and 3 sell ratings.
What is Bristol-Myers Squibb’s share price target?
The average share price target for Bristol-Myers Squibb is €43.45. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €55.32 ,and the lowest forecast is €29.53. The average share price target represents 1.03% Increase from the current price of €43.01.
The highest analyst share price target is €55.32 ,and the lowest forecast is €29.53. The average share price target represents 1.03% Increase from the current price of €43.01.
What do analysts say about Bristol-Myers Squibb?
Bristol-Myers Squibb’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Bristol-Myers Squibb?
To buy shares of DE:BRM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.